Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRAT | O95237 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GJA1 | P17302 | 1/20 | 0.36 |
| ▸ | GJB2 | P29033 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8218250 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL11289960 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL11505783 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL10870794 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL10870801 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL23231183 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL16181597 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL12685581 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL21454659 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 | |
| SCHEMBL8218251 | 1.00 | LRAT (0.45) | LRATLMNAKDM4EALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9468595-B2 | Acrylamide derivatives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-10-18 | — | — | US | disclosed |
| US-9238774-B2 | Soil fixation, dust suppression and water retention | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-01-19 | — | — | US | disclosed |
| US-9238774-B2 | Soil fixation, dust suppression and water retention | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-01-19 | — | — | US | disclosed |
| US-9238774-B2 | Soil fixation, dust suppression and water retention | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-01-19 | — | — | US | disclosed |
| US-9212245-B2 | High performance acrylamide adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212245-B2 | High performance acrylamide adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212245-B2 | High performance acrylamide adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-15 | — | — | US | disclosed |
| US-20140178344-A1 | ACRYLAMIDE HYDROGELS FOR TISSUE ENGINEERING | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-06-26 | — | — | US | disclosed |
| US-20140178344-A1 | ACRYLAMIDE HYDROGELS FOR TISSUE ENGINEERING | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-06-26 | — | — | US | disclosed |
| US-20140178344-A1 | ACRYLAMIDE HYDROGELS FOR TISSUE ENGINEERING | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-06-26 | — | — | US | disclosed |
| US-20140155563-A1 | HIGH PERFORMANCE ACRYLAMIDE ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140155563-A1 | HIGH PERFORMANCE ACRYLAMIDE ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140155563-A1 | HIGH PERFORMANCE ACRYLAMIDE ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-06-05 | — | — | US | disclosed |
| WO-2014070194-A1 | SOIL FIXATION, DUST SUPPRESSION AND WATER RETENTION | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20140126966-A1 | SOIL FIXATION, DUST SUPPRESSION AND WATER RETENTION | CRESTLINE DIRECT FINANCE, L.P. | 2014-05-08 | — | — | US | disclosed |
| US-20140126966-A1 | SOIL FIXATION, DUST SUPPRESSION AND WATER RETENTION | CRESTLINE DIRECT FINANCE, L.P. | 2014-05-08 | — | — | US | disclosed |
| US-20140126966-A1 | SOIL FIXATION, DUST SUPPRESSION AND WATER RETENTION | CRESTLINE DIRECT FINANCE, L.P. | 2014-05-08 | — | — | US | disclosed |
| US-8088626-B2 | Chiral selectors for separating enantiomers of a compound | University Joseph Fourier (Grenoble 1) (FR) | 2012-01-03 | — | — | US | disclosed |
| US-20100144045-A1 | CHIRAL SELECTORS FOR SEPARATING ENANTIOMERS OF A COMPOUND | UNIVERISTE JOSEPH FOURIER (GRENOBLE 1) (FR) | 2010-06-10 | — | — | US | disclosed |
| WO-2008132340-A2 | CHIRAL SELECTORS FOR SEPARATING ENANTIOMERS OF A COMPOUND | UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144045-A1 | CHIRAL SELECTORS FOR SEPARATING ENANTIOMERS OF A COMPOUND | CD2, CD22, CA2 | LRAT 2404/4885LMNA 4394/4885KDM4E 2950/4885 |
| US-20140155563-A1 | HIGH PERFORMANCE ACRYLAMIDE ADHESIVES | ITGAM, WASF2, EPCAM | LRAT 1860/4885LMNA 3918/4885KDM4E 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.